Quick Answer
Tanke Biosciences Corp reported Gross Profit of $9.94 million for the year ending 2012.
- Tanke Biosciences Corp showed an increase of +13.4% in Gross Profit from 2011 to 2012.
- This data is from Tanke Biosciences Corp's annual report (Form 10-K), filed with the SEC on April 15, 2013.
- XBRL data for this metric is available from 2010 to 2012 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $2.43 million | Q3 2011: $2.24 million | Q1 2012: $1.59 million | Q2 2012: $2.74 million | Q3 2012: $3.39 million | Q1 2013: $1.67 million | Q2 2013: $1.82 million | Q3 2013: $1.69 million.
- Over the full 3 years of available data (2010 to 2012), Tanke Biosciences Corp's Gross Profit has grown by 34.4%.
- Historical annual values: Fiscal year 2012: $9.94 million | Fiscal year 2011: $8.77 million | Fiscal year 2010: $7.40 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: